股市必读：天臣医疗（688013）预计2025年全年归属净利润盈利8289.48万元至8889.48万元

Group 1 - The core viewpoint of the article highlights Tianchen Medical's expected profit growth for 2025, driven by stable sales of its endoscopic stapler products and increased exchange gains [3][4][5] Group 2 - As of January 30, 2026, Tianchen Medical's stock closed at 42.8 yuan, with a 1.18% increase and a turnover rate of 1.45%, totaling a trading volume of 11,700 shares and a transaction amount of 49.8263 million yuan [1] - On January 30, the net outflow of main funds was 5.0786 million yuan, accounting for 10.19% of the total transaction amount, while retail investors saw a net inflow of 3.6276 million yuan, representing 7.28% of the total [2][5] - Tianchen Medical forecasts a net profit attributable to shareholders of 82.8948 million to 88.8948 million yuan for the full year of 2025, with a non-GAAP net profit expected to be between 73.7408 million and 77.7408 million yuan [3][4]